Monday 3 May 2021

Personalization of follow-up care needed to address varying health burdens in breast cancer patients

With breast cancer considered a largely curable disease (more than 70% of survivors live at least 10 years after diagnosis), quality of life care is seen as a key aspect in the patients cancer journey.  At the recent ESMO Breast Cancer 2021 Virtual Congress, a study from the Netherlands Cancer Institute in Amsterdam showed that "breast cancer survivors differ widely in the burden of symptoms they experience after the end of treatment and thereby revealed an unmet need for tailored approaches to follow-up care."  According to breast cancer expert Nadia Harbeck, patients "need to be well-informed and must be made to feel comfortable about contacting their physician outside of their planned consultations if necessary." 

To read more about this study, click here

Sources mentioned: 

F. Cardoso, S. Kyriakides, S. Ohno, F. Penault-Llorca, P. Poortmans, I. T. Rubio, S. Zackrisson and E. Senkus. Early Breast Cancer: ESMO Clinical Practice Guidelines. https://doi.org/10.1093/annonc/mdz173 

Abstract 134P_PR ‘Towards tailored follow-up care for breast cancer survivors: cluster analyses based on symptom burden’ will be available as e-Poster from Wednesday 5 May at 09:00 CEST. Annals of Oncology, Volume 32, Supplement 2, May 2021 

Abstract 140P ‘How breast cancer recurrences are found? - a real-world, prospective cohort study’ will be available as e-Poster from Wednesday 5 May at 09:00 CEST. Annals of Oncology, Volume 32, Supplement 2, May 2021 

No comments:

Post a Comment